On top of that there are the synergy benefits from merging the Crazy Prices stores with Miller's 170 Crazy Clark's and Go-Lo stores. The deal is expected to be finalised within the week. Cellestis up and about The biotech sector's newest baby, Cellestis, has shaken off an initial investor chill. The shares have since soared, hitting a high of 60c yesterday before closing at 52c, up 3c. When the stock exchange asked what's been going on, the company said nothing that hadn't already been printed in the prospectus.
Analysts think it's just a case of investors warming to the cause.
They particularly like the bit where the company is apparently in preliminary talks with the US military about the use of Cellestis's Qantiferon-TB kit.